Related Experiment Video
Updated: Mar 7, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
Nrf2 mediates redox adaptation in NOX4-overexpressed non-small cell lung cancer cells
Qipeng Wu1, Bei Yao1, Ning Li1
1Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Abstract:
The redox adaptation mechanisms in cancer cells are very complex and remain largely unclear. Our previous studies have confirmed that NADPH oxidase 4 (NOX4) is abundantly expressed in non-small cell lung cancer (NSCLC) and confers apoptosis resistance on NSCLC cells. However, the comprehensive mechanisms for NOX4-mediated oxidative resistance of cancer cells remain still undentified. The present study found that NOX4-derived H2O2 enhanced the nuclear factor erythroid 2-related factor 2 (Nrf2) stability via disruption of redox-dependent proteasomal degradation and stimulated its activity through activation of PI3K signaling. Specifically, the results showed that ectopic NOX4 expression did not induce apoptosis of A549 cells; however, inhibition of Nrf2 resulted in obvious apoptotic death of NOX4-overexpressed A549 cells, accompanied by a significant increase in H2O2 level and decrease in GSH content. Besides, inhibition of Nrf2 could suppress cell growth and efficiently reverse the enhancement effect of NOX4 on cell growth. The in vivo data confirmed that inhibition of Nrf2 could interfere apoptosis resistance in NOX4-overexpressed A549 tumors and led to cell growth inhibition. In conclusion, these results reveal that Nrf2 is critically involved in redox adaptation regulation in NOX4-overexpressed NSCLC cells. Therefore, NOX4 and Nrf2 may be promising combination targets against malignant progression of NSCLC.
Insights
NADPH oxidase 4 (NOX4) confers apoptosis resistance in non-small cell lung cancer (NSCLC) by stabilizing nuclear factor erythroid 2-related factor 2 (Nrf2). Inhibiting Nrf2 overcomes this resistance, offering potential therapeutic targets for NSCLC.
Area of Science:
- Cellular Biology
- Cancer Research
- Redox Biology
Background:
- Redox adaptation mechanisms in cancer are complex and poorly understood.
- NADPH oxidase 4 (NOX4) is highly expressed in non-small cell lung cancer (NSCLC) and promotes apoptosis resistance.
- The precise mechanisms of NOX4-mediated oxidative resistance in cancer cells require further elucidation.
Purpose of the Study:
- To investigate the comprehensive mechanisms underlying NOX4-mediated oxidative resistance in NSCLC.
- To determine the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in NOX4-driven cancer cell adaptation.
Main Methods:
- Studied NOX4 expression in NSCLC cells.
- Utilized ectopic NOX4 expression and Nrf2 inhibition in A549 cells.
- Assessed apoptosis, hydrogen peroxide (H2O2) levels, glutathione (GSH) content, and cell growth.
- Conducted in vivo studies using xenograft tumor models.
Main Results:
- NOX4-derived H2O2 enhanced Nrf2 stability by disrupting proteasomal degradation and increased Nrf2 activity via PI3K signaling.
- Inhibition of Nrf2 induced apoptosis in NOX4-overexpressing A549 cells, increasing H2O2 and decreasing GSH.
- Nrf2 inhibition suppressed cell growth and reversed NOX4-mediated growth enhancement, confirmed in vivo.
Conclusions:
- Nrf2 plays a critical role in redox adaptation within NOX4-overexpressing NSCLC cells.
- The NOX4-H2O2-Nrf2 axis is a key pathway for NSCLC cell survival and proliferation.
- Targeting both NOX4 and Nrf2 simultaneously presents a promising strategy against NSCLC progression.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Redox Reactions
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

